Pharma & Biotech
Revive Therapeutics returns with repurposed gout drug to fight COVID-19 and push into psychedelic medicine
Kazia Therapeutics sees 2020 as crucial inflection point for oncology programs
Healthcare company Exactus has diversified to pursue opportunities in hemp derived CBD products
Only registered members can use this feature.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.